M&A Deal Summary

Capsugel Belgium NV Acquires Bend Research

On September 5, 2013, Capsugel Belgium NV acquired life science company Bend Research

Acquisition Highlights
  • This is Capsugel Belgium NV’s 3rd transaction in the Life Science sector.
  • This is Capsugel Belgium NV’s 1st transaction in the United States.
  • This is Capsugel Belgium NV’s 1st transaction in Oregon.

M&A Deal Summary
Date 2013-09-05
Target Bend Research
Sector Life Science
Buyer(s) Capsugel Belgium NV
Deal Type Add-on Acquisition

Target

Bend Research

Bend, Oregon, United States
Bend Research has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company’s ability to develop, advance, and commercialize pharmaceutical technologies, which grow from a solid base of scientific and engineering fundamental understanding. Bend Research provides several capabilities, including formulation and dosage-form support, assists in process development and optimization, manufactures clinical trial quantities of drug candidates in its cGMP facilities, and advances promising drug candidates from conception through commercialization.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Capsugel Belgium NV

Colmar, France
Category Company
Founded 1875
Sector Life Science
Revenue 750M USD (2010)
DESCRIPTION

Capsugel Belgium NV is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Capsugel offers a comprehensive array of products and services, from hard gelatin, vegetarian and liquid-filled capsules, to innovative R&D equipment and liquid formulations as part of its Licaps Drug Delivery System.

DEAL STATS #
Overall 3 of 5
Sector (Life Science) 3 of 5
Type (Add-on Acquisition) 2 of 4
State (Oregon) 1 of 1
Country (United States) 1 of 3
Year (2013) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-01 MW Encap

Livingston, United Kingdom

Encap Drug Delivery focus on liquid and semi-solid encapsulation-based product development, and clinical and commercial manufacturing for the pharmaceutical industry. Encap operates an FDA and MHRA inspected pharmaceutical product development and manufacturing site, is equipped to handle high potency active ingredients, and has established a clinical fast-track program that can speed the process from lab to clinic.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-14 PowderSize

Quakertown, Pennsylvania, United States

Powdersize is a customer service-driven contract manufacturer, providing expertise in particle-size reduction and particle-size control technologies intended for powders used within the pharmaceutical, medical and food marketplaces. With two decades of manufacturing experience, Powdersize can develop a robust process at any scale of development, including R&D, pilot scale or commercial scale. The company combines extensive experience and its unique ability to design custom jet milling systems appropriate for the client’s need. The company is one of the leading contract manufacturers offering milling and micronization services in the United States.

Buy -
Mergr

Product

Company

Legal